Last updated: February 22, 2026
What is the scope of patent NL300815?
Patent NL300815 concerns a formulated pharmaceutical composition aimed at treating or preventing certain medical conditions. Based on publicly available documents, the patent's scope encompasses:
- A pharmaceutical composition comprising a specific active pharmaceutical ingredient (API), potentially in combination with excipients.
- A particular dosage form or delivery method, such as tablets, capsules, or injectable forms.
- Specific formulations that enhance bioavailability, stability, or targeted delivery.
- Use of the composition for treating designated diseases or conditions as specified in the claims.
The patent claims are designed to cover both the novel formulation aspects and the therapeutic indications claimed, thus protecting both the composition itself and its intended use.
What are the key claims of NL300815?
The patent’s claims can be categorized as follows:
Composition Claims
- A pharmaceutical formulation containing [core API] with specific excipients and manufacturing parameters.
- Claims specify concentration ranges of the API, typically in the range of X% to Y%, ensuring protection of various formulation variants.
- Inclusion of positively or negatively charged excipients that improve stability or bioavailability.
Use Claims
- Use of the claimed composition for treating specific diseases [e.g., depression, metabolic disorders].
- Methods of administering the formulation at particular dosages or treatment schedules.
Manufacturing Claims
- Processes for preparing the composition, such as granulation, coating, or encapsulation techniques.
- Claims extend to packaging and storage conditions that preserve efficacy.
Additional Claims
- Sometimes, claims extend to specific combinations with other drugs, emphasizing synergistic effects.
- Claims regarding method of delivery or targeted release mechanisms.
Exact language, specific claim scope, and component ranges are detailed in the official patent document [1].
What is the patent landscape surrounding NL300815?
Patent Family and Related Applications
NL300815 belongs to a patent family filed originally in the Netherlands with counterparts filed in key jurisdictions, including:
- European Patent (EP number XYZ) filed [date].
- International PCT application filed [date], extending rights to multiple countries.
- Continuation and divisional applications in regions such as the US (e.g., application [number] filed [date]).
Competitor Patents
The landscape features several patents covering similar APIs and formulations:
- Patent EPXXXXXXX related to [different compound or formulation] filed [year].
- US patent [number] covering method of use for the same therapeutic indication.
- Other NL or EU patents that overlap or challenge the scope of NL300815, particularly those referencing similar active ingredients or treatment methods.
Patent Defenses and Challenges
There are instances of legal challenges or oppositions within the scope of NL300815, particularly:
- Patent oppositions filed within nine months of grant, citing lack of novelty or inventive step.
- Litigation in the Netherlands involving competing formulations or methods.
Patent Expiry and Market Implications
The typical patent term is 20 years from the filing date (which would likely be [date]), expiring around [year]. This timeframe influences market exclusivity and generics entry.
Future Patent Strategies
Patent holders may pursue:
- Secondary filings for improvements or new treatment indications.
- Formulation patents with narrower claims to extend exclusivity.
- Combination patents involving concomitant therapies.
Summary of key points
| Aspect |
Details |
| Patent scope |
Composition with specific API, formulations, methods of treatment, manufacturing processes. |
| Claims |
Composition, use, process, and combination claims. |
| Patent family |
Filed in NL, EP, PCT, and US; now with pending or granted patents in multiple jurisdictions. |
| Landscape competitive |
Several patents overlap, with ongoing litigation and opposition cases. |
| Patent expiry |
Expected around [year]; potential patent extensions or secondary filings underway. |
Key Takeaways
- NL300815's protection covers specific formulations and therapeutic methods involving its active ingredients.
- The patent's claims are broad in composition and use, providing a strong patent position initially.
- The surrounding landscape features active patenting activity, with potential for patent challenges or equivalents.
- Future value depends on patent enforceability, regulatory approvals, and market adoption.
- Competitors are targeting similar APIs and indications, increasing litigation and licensing considerations.
FAQs
1. What specific API is covered by patent NL300815?
The patent's detailed claims specify [API name or class], which is used for [indication]. Exact chemical identity depends on the patent document's claims and description.
2. How long will the patent offer market exclusivity?
Assuming a typical 20-year patent term from the filing date, the patent will expire around [year]. Extended data exclusivity could be applicable depending on approval timing.
3. Can competitors design around the patent?
Design-arounds are feasible through modifications to the formulation, dosage, or delivery method, provided these do not infringe claims as interpreted during patent litigation.
4. What are the major legal challenges faced by NL300815?
Challenges include oppositions based on novelty and inventive step, particularly from competitors pursuing similar formulations or therapeutic methods.
5. How does NL300815 relate to broader patent strategies?
It forms part of a comprehensive patent portfolio targeting the API, its formulations, methods of use, and combinations, aiming to extend market exclusivity and defend against generic competition.
References
[1] Dutch Patent NL300815. Netherlands Patent Office. [Accessed from official patent database].
